Premium
Septerna Inc (SEPN)
NASDAQ
Hot Features
Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
| Actionnaire | Type | Détenues (Réel) | % en Circulation | Valeur Marchande | Date de Reporte |
|---|---|---|---|---|---|
| Third Rock Ventures, LLC | Institution | 10 427 250 | 23,13% | US$ 327,10M | 2026-03-31 |
| RA Capital Management, L.P. | Institution | 6 995 858 | 15,52% | US$ 219,46M | 2026-03-31 |
| Third Rock Ventures V, LP | Institution | 6 215 591 | 13,79% | US$ 194,98M | 2025-04-21 |
| RA Capital Healthcare Fund, L.P. | Institution | 5 523 915 | 12,25% | US$ 173,29M | 2025-04-21 |
| Driehaus Capital Management LLC | Institution | 4 395 572 | 9,75% | US$ 137,89M | 2026-03-31 |
| Third Rock Ventures VI, L.P. | Institution | 4 211 659 | 9,34% | US$ 132,12M | 2025-04-21 |
| Samsara BioCapital LLC | Institution | 3 149 128 | 6,99% | US$ 98,79M | 2026-03-31 |
| Samsara Biocapital, L.P. | Institution | 2 768 520 | 6,14% | US$ 86,85M | 2024-10-28 |
| Artal Group S.A. | Institution | 2 000 000 | 4,44% | US$ 62,74M | 2026-03-31 |
| BlackRock, Inc. | Institution | 1 822 174 | 4,04% | US$ 57,16M | 2026-03-31 |
| Invus Public Equities, L.P. | Institution | 1 577 514 | 3,50% | US$ 49,49M | 2024-10-25 |
| The Goldman Sachs Group, Inc. | Institution | 1 473 610 | 3,27% | US$ 46,23M | 2026-03-31 |
| RA Capital Nexus Fund III, L.P. | Institution | 1 471 943 | 3,27% | US$ 46,17M | 2025-04-21 |
| Goldman Sachs Asset Management, L.P. | Institution | 1 432 817 | 3,18% | US$ 44,95M | 2026-03-31 |
| Deep Track Biotechnology Master Fund, Ltd | Institution | 1 412 929 | 3,13% | US$ 44,32M | 2024-10-25 |
| BVF Partners L.P. | Institution | 1 353 249 | 3,00% | US$ 42,45M | 2026-03-31 |
| Avoro Capital Advisors LLC | Institution | 1 337 500 | 2,97% | US$ 41,96M | 2026-03-31 |
| Vanguard Capital Management, LLC | Institution | 1 196 962 | 2,66% | US$ 37,55M | 2026-03-31 |
| ADAR1 Capital Management, LLC | Institution | 1 089 818 | 2,42% | US$ 34,19M | 2026-03-31 |
| PRIMECAP Management Company | Institution | 1 048 834 | 2,33% | US$ 32,90M | 2026-03-31 |
| Biotechnology Value Fund L.P. | Institution | 919 814 | 2,04% | US$ 28,85M | 2025-12-31 |
| Janus Henderson Group plc | Institution | 890 754 | 1,98% | US$ 27,94M | 2026-03-31 |
| Dr. Jeffrey Finer | Initiés | 775 408 | 1,72% | US$ 24,32M | 2026-04-29 |
| West Street Life Sciences I, L.P. | Institution | 760 738 | 1,69% | US$ 23,86M | 2024-10-25 |
| First Light Asset Management, LLC | Institution | 732 860 | 1,63% | US$ 22,99M | 2026-03-31 |
| Biotechnology Value Fund II, L.P. | Institution | 671 492 | 1,49% | US$ 21,06M | 2025-12-31 |
| Geode Capital Management, LLC | Institution | 645 146 | 1,43% | US$ 20,24M | 2026-03-31 |
| State Street Global Advisors, Inc. | Institution | 631 447 | 1,40% | US$ 19,81M | 2026-03-31 |
| Casdin Capital, LLC | Institution | 553 268 | 1,23% | US$ 17,36M | 2026-03-31 |
| VR Management, LLC | Institution | 506 056 | 1,12% | US$ 15,87M | 2026-03-31 |
| Catalio Capital Management, LP | Institution | 294 360 | 0,65% | US$ 9,23M | 2026-03-31 |
| Soleus Capital Management, L.P. | Institution | 275 000 | 0,61% | US$ 8,63M | 2026-03-31 |
| Balyasny Asset Management L.P. | Institution | 236 679 | 0,53% | US$ 7,42M | 2026-03-31 |
| Universal Investment GmbH | Institution | 223 995 | 0,50% | US$ 7,03M | 2026-03-31 |
| Vanguard Portfolio Management, LLC | Institution | 195 043 | 0,43% | US$ 6,12M | 2026-03-31 |
| Kalehua Capital Management LLC | Institution | 194 544 | 0,43% | US$ 6,10M | 2026-03-31 |
| Charles Schwab Investment Management, Inc. | Institution | 181 580 | 0,40% | US$ 5,70M | 2026-03-31 |
| Broad Street Principal Investments, L.L.C. | Institution | 181 212 | 0,40% | US$ 5,68M | 2024-10-25 |
| Ms. Elizabeth Bhatt | Initiés | 166 951 | 0,37% | US$ 5,24M | 2026-04-29 |
| Northern Trust Global Investments | Institution | 164 530 | 0,37% | US$ 5,16M | 2026-03-31 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
S'inscrire avec l'e-mail
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.
